Histopathological study of prostatic lesions in correlation with serum prostate specific antigen levels in elderly men

Nikhil S. Deshpande, Swati V. Dahe, Anil B. Munemane, Gajanan D. Dhokikar, Ravindra R. Karle


Background: Prostatic lesions are common among elderly men with urinary complaints. Variety of prostatic lesions range from inflammatory, benign to malignant pathologies. The Prostate specific antigen (PSA) is secreted by glandular epithelium of prostate shows raised serum levels in these pathologies. Usually significant rise is commonly associated with Prostatic adenocarcinomas (PCa) with exceptions.

Methods: In this retrospective study, total 63 diagnosed cases of prostatic lesions over a one-year period for which serum PSA levels were available, were selected. Cases without serum PSA levels & inadequate biopsies were excluded. Histological diagnosis of prostatic lesions reconfirmed and its correlation with serum PSA was done.

Results: Study included patients with mean age 67.84 years (range: 48-60) at the time of diagnosis. Benign lesions were commonest prostatic lesions accounting for total 54 cases (85.71%) out of which 38 were of Benign prostatic hyperplasia (BPH), 14 cases of BPH with prostatitis while single case each for BPH with granulomatous prostatitis and basal cell hyperplasia. Mean PSA value for benign lesions was 6.57 ng/ml. Total 8 were malignant which included 7 (11.11%) PCa while single (1.59%) case of metastatic transitional cell carcinoma. Mean PSA for PCa were 35.05 ng/ml. Single case (1.59%) of high grade prostatic intraepithelial neoplasia also detected.

Conclusion: Common age group at the time of presentation of prostatic pathologies is 60-70 years. The most common prostatic lesions are benign predominantly BPH. PCa are commonest malignancies. Elevated PSA levels >20 ng/ml are commonly observed in PCa. However lower or normal values don’t rule out PCa.


PSA, BPH, Prostatitis, Prostatic adenocarcinoma

Full Text:



Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Available from: http:/lglobocan.iarc fr: International Agency for Research on Cancer. Accessed on 4th August 2020.

Jain S, Saxena S, Kumar A. Epidemiology of prostate cancer in India. Meta Gene. 2014;2:59-605.

Ornstein DK, Pruthi RS. Prostate-specific antigen. Expert Opin Pharmacother. 2000;1:1399-411.

Aus G, Damber JE, Khatami A, Lilja H, Stranne J, Hugosson J. Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study. Arch Intern Med. 2005;165(1):857-61.

Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004;350:2239-46.

Tchetgen MB, Oesterling JE. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am. 1997;24(2):283-91.

Parthiban R, Roopa AN, Puttaswamy K, Shariff S. Efficacy of prostate-specific antigen to categorize men with prostate pathology into benign, premalignant, and malignant lesions. J Med Sci Health. 2016;2(1):1-5.

Agrawal A, Karan SC. Serum PSA levels in the Indian population: Is it different? Med J Armed Forces India. 2017;73(2):112-7.

Chauhan SC, Sarvaiya AN. Study of clinicomorphologic spectrum of prostatic lesions and correlation with prostate specific antigen levels in a tertiary care center. 2017;4:328-32.

Lakhey M, Ghimire R, Shrestha R, Bhatta AD. Correlation of serum free prostate-specific antigen level with histological findings in patients with prostatic disease. Kathmandu University Medical J. 2010;8(2):158-63.

Vani BR, Kumar D, Sharath BN, Murthy VS, Geethamala K. A Comprehensive Study of Prostate Pathology in Correlation with Prostate-Specific Antigen Levels: An Indian Study. Clinc Cancer Investig J. 2015;4:617-20.

Javed R, Suresh T, Shetty M. Study of morphological spectrum of prostatic lesions and its correlation with Ki-67 in a tertiary care hospital in rural South India. Al Ameen J Med Sci. 2016;9(3):175-82.

Jayapradeep DP, Prakash VB, Philipose TR, Pai MR. Histomorphological correlation of PSA levels in prostatic carcinoma. National J Lab Med. 2017;6:28-32.

Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R. Correlation between prostate specific antigen levels and various pathologies. J Med Soc. 2016;30:172-5.

Godbole CR, Bhide SP. Study of histopathological correlation of prostate lesions with serum prostate specific antigen levels in a tertiary care hospital. MedPulse Int J Pathol. 2020;13(3):125-9.

Wadgaonkar AR, Patil AA, Mahajan SV, Yengantiwar RP. Correlation of serum prostate specific antigen level in various prostatic pathology in elderly men. Int J Basic Appl Med Sci. 2013;3:274-81.

Akhter R, Reshi R, Dar ZA, Dar PA. Histopathological study of prostatic lesions on needle biopsies with serum prostate-specific antigen (PSA). Int J Med Med Sci. 2014;6(3):87-91.